Latest Derivatives News

Resimac Group reported a 13% rise in operating profit for FY25, driven by strong asset growth and a major auto finance acquisition, while declaring a total dividend of 19 cents per share.

Resimac Group Ltd reported a stable FY25 net profit after tax of $34.6 million and declared a fully franked final dividend of 3.5 cents per share, maintaining its steady financial footing amid modest revenue growth.

AI-Media Technologies marked FY25 as a pivotal year, transitioning to a technology-led business with 63% of revenue from tech products and launching LEXI Voice. The company expanded its global footprint to 36 countries and set ambitious targets for FY29.

Macquarie Technology Group Limited reported solid FY25 results with continued EBITDA growth and strong cash conversion, underpinned by strategic investments in data centre capacity and AI capabilities.

Global Health Limited reported a reduced net loss for FY2025, driven by growing subscription revenue and strategic AI integration as it transitions to a SaaS platform.

Ark Mines reports its Stage-3 drilling at Sandy Mitchell is ahead of schedule, aiming to nearly quintuple its measured mineral resource and fuel a pivotal Pre-Feasibility Study.

L1 Long Short Fund Limited reported a net profit after tax of $99.52 million for FY2025, down 42% year-on-year, yet continues its steady dividend growth with a fully franked final dividend of 6.5 cents per share.

Worley Limited posted robust full-year 2025 results, marked by strong revenue growth, margin expansion, and a significant increase in backlog, underpinned by major contract wins and sustainability progress.

Ingenia Communities Group reported a 9.6% rise in revenue to $517.7 million for FY25, driven by strong home settlements and rental income growth. Underlying profit surged 33% to $126.1 million, while statutory profit soared 816%, reflecting prior year impairments and fair value gains.

Carindale Property Trust reported a solid 6.4% increase in revenue to $61.6 million and a significant jump in net profit to $39.2 million for the year ended 30 June 2025, underpinned by strong property valuations and operational performance.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Tribeca Global Natural Resources Limited announces a fully franked $0.05 final dividend for FY25 alongside amendments to its Dividend Reinvestment Plan designed to protect shareholder value. The company also launches a 10% on-market share buy-back aiming to capitalize on shares trading below net tangible asset backing.